# EDGAR Filing Document

**Accession Number:** 0000921582
**File Stem:** 0001628280-26-022043
**Filing Date:** 2026-3
**Character Count:** 8587
**Document Hash:** a832864e387243bea217fd453f32c3c1
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001628280-26-022043.hdr.sgml**: 20260330

**ACCESSION NUMBER**: 0001628280-26-022043

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 13

**CONFORMED PERIOD OF REPORT**: 20260330

**ITEM INFORMATION**: Regulation FD Disclosure

**FILED AS OF DATE**: 20260330

**DATE AS OF CHANGE**: 20260330

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IMAX CORP
- **CENTRAL INDEX KEY:** 0000921582
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHOTOGRAPHIC EQUIPMENT & SUPPLIES [3861]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 980140269
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35066
- **FILM NUMBER:** 26813489

**BUSINESS ADDRESS:**
- **STREET 1:** 2525 SPEAKMAN DRIVE
- **CITY:** MISSISSAUGA
- **STATE:** A6
- **ZIP:** L5K 1B1
- **BUSINESS PHONE:** 9054036500

**MAIL ADDRESS:**
- **STREET 1:** 2525 SPEAKMAN DRIVE
- **CITY:** MISSISSAUGA
- **STATE:** A6
- **ZIP:** L5K 1B1

?xml version='1.0' encoding='ASCII'? imax-20260330

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(D)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**March 30, 2026**

**Date of report (Date of earliest event reported)**

**IMAX Corporation**

**(Exact Name of Registrant as Specified in Its Charter)**

---

| | | |
|:---|:---|:---|
| **Canada** | **001-35066** | **98-0140269** |
| **(State or Other Jurisdiction**<br>**of Incorporation)** | **(Commission**<br>**File Number)** | **(I.R.S. Employer**<br>**Identification Number)** |

---

---

| | |
|:---|:---|
| **2525 Speakman Drive** | **902 Broadway, Floor 20** |
| **Mississauga, Ontario, Canada L5K 1B1** | **New York, New York, USA 10010** |
| **(905) 403-6457** | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**(212) 821-0142** |

---

**(Address of principal executive offices, zip code, telephone numbers)**

**N/A**

**(Former Name or Former Address, if Changed Since Last Report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading**<br>**Symbol(s)** | **Name of each exchange**<br>**on which registered** |
| **Common Shares, no par value** | **IMAX** | **The New York Stock Exchange** |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter):

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 7.01 Regulation FD Disclosure.**

On March 30, 2026, IMAX Corporation (the "Company") issued a press release announcing that Richard Gelfond, the Company's Chief Executive Officer, is on a temporary medical leave of absence. During his temporary absence, the Company's senior executives are executing their day-to-day responsibilities in coordination with each other and Darren Throop, Chair of the Board of Directors, with regular communication with the full Board of Directors. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information in this Item 7.01 of this current report on Form 8-K, including Exhibit 99.1 attached hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits.

---

| | |
|:---|:---|
| **Exhibit**<br>**No.** | **<u>Description</u>** |
| 99.1 | <u>[Press Release dated](exhibit991march302026press.htm)[March](exhibit991march302026press.htm)[30](exhibit991march302026press.htm)[, 202](exhibit991march302026press.htm)6</u> |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL). |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | **IMAX Corporation** | **IMAX Corporation** |
| | (Registrant) | (Registrant) |
| Date: March 30, 2026 | By: | /s/ Robert D. Lister |
|  | Name: | Robert D. Lister |
|  | Title: | Chief Legal Officer and Senior Executive Vice President |
|  | By: | /s/ Kenneth I. Weissman |
|  | Name: | Kenneth I. Weissman |
|  | Title: | Deputy General Counsel & Corporate Secretary |

---

## Exhibit 99.1

**<u>Exhibit 99.1</u>**

**IMAX Corporation Announces CEO Richard Gelfond Taking Temporary Medical Leave of Absence**

**NEW YORK — March 30, 2026 —** IMAX Corporation (NYSE: IMAX) today announced CEO Richard Gelfond is on a temporary medical leave of absence as he undergoes treatment for pneumonia. He is receiving outstanding care and progressing in his recovery.

While he receives medical care and recovers, Mr. Gelfond will not be participating in any public or private events for the Company. Consistent with its operating plan in the event of Mr. Gelfond's temporary absence, the Company's senior executives are executing their day-to-day responsibilities in coordination with each other and Board Chairman Darren Throop, with regular communication with the full Board of Directors. Among the senior executive team are the company's Named Executive Officers:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Natasha Fernandes, EVP and Chief Financial Officer (19 years at IMAX)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Anne Globe, Chief Marketing Officer (2 years)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Rob Lister, Sr. EVP and Chief Legal Officer (27 years)

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;• Mark Welton, President, IMAX Theatres (28 years)

IMAX is issuing this statement to provide transparency and ensure that there is no speculation arising out of Mr. Gelfond not appearing at the Company's upcoming events, including next week's industry conferences. Out of respect for Mr. Gelfond's privacy as he is being treated, IMAX will not provide further comment at this time, but will provide updates as appropriate.

Mr. Throop offered the following statement: "We have a strong, deeply experienced senior executive team who are fully engaged, providing regular updates to the Board, and remain focused as always on the continued growth and success of IMAX. We are all wishing Rich well and a full and speedy recovery."

**About IMAX Corporation**

IMAX (NYSE: IMAX) is a global leader in entertainment technology, delivering immersive cinematic experiences through proprietary software, architecture, and projection systems. Filmmakers, studios, and artists worldwide use IMAX to connect with audiences at scale, making its network one of the most powerful platforms for blockbuster events and entertainment.

Headquartered in New York, Toronto, and Los Angeles, IMAX operates 1,864 systems across 91 countries and territories as of December 31, 2025. IMAX China Holding, Inc., a subsidiary of IMAX Corporation, trades on the Hong Kong Stock Exchange under stock code "1970." IMAX and related marks are trademarks of IMAX Corporation. For more information, visit www.imax.com.

For additional information please contact:

------

**Investors:** Jennifer Horsley jhorsley@imax.com

**Media:** Mark Jafar

mjafar@imax.com

<br>